USPTO trademark

Crinetics Pharmaceuticals, Inc design mark 99187857

AllowedUSPTOFigurative markClass 5

"Design mark 99187857" is a figurative mark owned by Crinetics Pharmaceuticals, Inc., filed at the USPTO on May 15, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

Get this data via the API
Official USPTO record
Crinetics Pharmaceuticals, Inc design mark 99187857 trademark as filed
As filed with the USPTO
Status
Allowed
Since September 29, 2026
Filed
May 15, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99187857
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns Crinetics Pharmaceuticals, Inc design mark 99187857

The owner and representative on file with the office.

Owner

Crinetics Pharmaceuticals, Inc.

San Diego, United States

Representative

Danny Awdeh

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Goods and services

What the mark covers

The products and services Crinetics Pharmaceuticals, Inc design mark 99187857 is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly; all for human use

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Extension of time to oppose process - terminated
  3. Extension of time to oppose received
  4. Official gazette publication confirmation e-mailed
  5. Published for opposition
  6. Notification of notice of publication e-mailed
  7. Approved for pub - principal register
  8. Teas/email correspondence entered
  9. Correspondence received in law office
  10. Teas response to office action received

10 earlier steps on the official record.

FAQ

About Crinetics Pharmaceuticals, Inc design mark 99187857

Who owns the trademark "Design mark 99187857"?

The USPTO trademark "Design mark 99187857" (application 99187857) is owned by Crinetics Pharmaceuticals, Inc.

What is the status of "Design mark 99187857"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Crinetics Pharmaceuticals, Inc design mark 99187857 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ac8-19b7-76e9-b1e8-33d3875116bd
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ac8-19b7-76e9-b1e8-33d3875116bd",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99187857",
  "filing_date": "2025-05-15",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Crinetics Pharmaceuticals, Inc.",
      "entity_id": null
    }
  ]
}